HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by paperbullon May 02, 2014 3:47pm

118 Views

Post# 22519384

RE:RE:RE:RE:Final accrued value

am new to this stock as well - though it hit my screeners last May after the freefall and I watched from the sidelines (for too long) while it recovered.

Factors for value investors are still in play even though this trades at $1.00 P/B. I agree the cash sheet & debt levels are pretty healthy. The dividend stance is pretty impressive - I've seen other companies cut their payouts for far less circumstance.

GLTA - and good weekend. If we all BBQ it'll contribute to a high pressure system and daytime highs over 16C (for once)

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale